Reports for APOTEX INC

Formerly known as AA PHARMA INC

Company Name
APOTEX INC

Shortage reports

Actual shortage:

220 (7%)

Anticipated shortage:

0 (0%)

Avoided shortage:

10 (0%)

Resolved:

3124 (93%)

3354

Discontinuation Reports

To be discontinued:

26 (7%)

Discontinued:

343 (93%)

Reversed:

0 (0%)

369

145 (4%)

73 (30%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-FELODIPINE 5MG TABLET (EXTENDED-RELEASE) Resolved 2023-07-21 2023-08-04 199527
APO-FELODIPINE 10MG TABLET (EXTENDED-RELEASE) Resolved 2024-09-12 2024-10-11 237378
APO-FELODIPINE 10MG TABLET (EXTENDED-RELEASE) Resolved 2023-11-24 2024-02-09 211484
APO-FELODIPINE 5MG TABLET (EXTENDED-RELEASE) Resolved 2020-08-26 2020-09-02 122994
APO-FELODIPINE 2.5MG TABLET (EXTENDED-RELEASE) Resolved 2020-08-06 2020-09-04 121903
APO-FELODIPINE 2.5MG TABLET (EXTENDED-RELEASE) Resolved 2019-10-16 2019-11-18 96647
APO-FELODIPINE 5MG TABLET (EXTENDED-RELEASE) Resolved 2023-11-17 2024-02-02 210689
APO-FELODIPINE 2.5MG TABLET (EXTENDED-RELEASE) Resolved 2017-08-08 2017-09-22 18543
APO-FELODIPINE 2.5MG TABLET (EXTENDED-RELEASE) Resolved 2024-01-19 2024-02-09 216662
APO-FELODIPINE 10MG TABLET (EXTENDED-RELEASE) Resolved 2022-12-23 2023-03-02 179447
APO-FELODIPINE 10MG TABLET (EXTENDED-RELEASE) Resolved 2023-06-23 2023-08-04 196300
APO-FELODIPINE 2.5MG TABLET (EXTENDED-RELEASE) Resolved 2023-06-16 2023-08-04 195091
APO-FELODIPINE 2.5MG TABLET (EXTENDED-RELEASE) Resolved 2023-02-09 2023-03-02 184086
APO-FELODIPINE 5MG TABLET (EXTENDED-RELEASE) Resolved 2022-12-23 2023-03-02 179444
APO-FELODIPINE 5MG TABLET (EXTENDED-RELEASE) Resolved 2024-08-15 2024-10-11 235345
APO-FELODIPINE 5MG TABLET (EXTENDED-RELEASE) Resolved 2025-01-09 2025-01-24 247391
APO-FELODIPINE 10MG TABLET (EXTENDED-RELEASE) Resolved 2025-01-09 2025-01-31 247394
APO-FINASTERIDE 5MG TABLET Resolved 2019-09-12 2019-10-01 93671
APO-FINASTERIDE 5MG TABLET Resolved 2019-04-04 2019-08-02 80533
APO-FINASTERIDE 5MG TABLET Actual shortage 2024-01-19 2024-02-16 216684
Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-QUETIAPINE 25MG TABLET Discontinued 2020-07-10 2020-07-10 119950
APO-QUININE 200MG CAPSULE Discontinued 2018-09-08 2021-05-10 60711
APO-QUININE 300MG CAPSULE Discontinued 2018-09-08 2021-05-10 60714
APO-RABEPRAZOLE 20MG TABLET (ENTERIC-COATED) Discontinued 2019-01-04 2019-01-04 71201
APO-RABEPRAZOLE 10MG TABLET (ENTERIC-COATED) Discontinued 2019-01-04 2019-01-04 71204
APO-RABEPRAZOLE 10MG TABLET (ENTERIC-COATED) Discontinued 2018-02-23 2019-09-12 40805
APO-RABEPRAZOLE 20MG TABLET (ENTERIC-COATED) Discontinued 2018-09-08 2018-10-05 60717
APO-RAMIPRIL 1.25MG CAPSULE Discontinued 2018-09-08 2019-03-29 60720
APO-RANITIDINE TABLET 150MG 150MG TABLET Discontinued 2018-09-08 2018-12-28 60726
APO-RANITIDINE TABLET 150MG 150MG TABLET Discontinued 2018-09-08 2019-02-13 60723
APO-RANITIDINE TABLET 150MG 150MG TABLET Discontinued 2019-01-02 2019-01-09 70810
APO-RANITIDINE TABLET 300MG 300MG TABLET To be discontinued 2018-09-08 2018-09-08 60732
APO-RANITIDINE TABLET 300MG 300MG TABLET Discontinued 2018-09-08 2018-09-15 60729
APO-REPAGLINIDE Discontinued 2018-09-08 2018-09-15 60735
APO-REPAGLINIDE Discontinued 2018-09-08 2018-09-15 60738
APO-REPAGLINIDE Discontinued 2018-09-08 2018-09-15 60741
APO-RILUZOLE 50MG TABLET To be discontinued 2025-12-02 2025-12-02 257819
APO-RILUZOLE 50MG TABLET To be discontinued 2018-09-08 2018-09-08 60744
APO-RISEDRONATE 35MG TABLET Discontinued 2018-09-08 2018-09-15 60747
APO-RISEDRONATE 35MG TABLET Discontinued 2018-10-19 2018-10-19 64965